News | April 12, 2026
Eli Lilly launches once-daily weight-loss pill Foundayo
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The event also featured discussions on emerging trends in joint replacement surgery
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
Subscribe To Our Newsletter & Stay Updated
